Dr. Man Hu 胡漫
Chief Physician
Department of Thoracic Radiation Oncology I, Cancer Hospital of Shandong First Medical University (Shandong Cancer Hospital), Jinan
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Proton therapy and functional imaging-guided precision radiotherapy, with a focus on standardized and individualized treatment for head and neck tumors and brain tumors.
Dr. Hu is a Chief Physician and visiting scholar at Harvard Medical School/Massachusetts General Hospital and Memorial Sloan Kettering Cancer Center. The doctor has published over 40 SCI papers, leads multiple research projects, and received awards including the Shandong Science and Technology Progress Award. Dr. Hu serves as Deputy Director of Ward 5 in the Radiotherapy Department.
Professional roles
- Chair, Tumor Radiotherapy Professional Committee, Shandong Pain Medicine Association
- Youth Member, Brain Glioma Professional Committee, China Anti-Cancer Association
- Member, Brain Glioma Professional Committee, Chinese Medical Doctor Association
- Member, Radiotherapy Group of Brain Glioma Professional Committee, China Anti-Cancer Association
Name order: in Chinese the family name comes first (Hu Man). Papers usually list the name as Man Hu or Hu M.
Selected publications
68 papers on PubMed matched by name and affiliation; 28 as first or senior author since 2016. Most recent first- or senior-author papers:
- Infect Dis Ther, 2026 (senior author): Pneumocystis jirovecii Pneumonia in Adults with Brain Tumors: Treatment-Related Risk, Diagnostic Challenges, and Evidence-Informed Prophylaxis-A Narrative Review. PubMed 42970042
- Recent Pat Anticancer Drug Discov, 2026 (first author): Cuproptosis-related Gene SLC31A1 Correlates with M2 Macrophage Infiltration and Serves as a Potential Therapeutic Target in Glioma: A Comprehensive Analysis of 1573 Samples from TCGA and CGGA Databases. PubMed 42460531
- Sci Rep, 2026 (senior author): Dose- and time-dependent relative biological effect of proton in different intracerebral cells. PubMed 41741545
- Recent Pat Anticancer Drug Discov, 2026 (senior author): Recent Advances in Proton Therapy for the Treatment of Skull Base Chordoma. PubMed 41582582
- Clin Nucl Med, 2026 (senior author): [18F]AlF-NOTA-PCP2 PET/CT to Assess PD-L1 Status in Head and Neck Cancer: Head-to-Head Comparison With [18F]FDG PET/CT. PubMed 41365504
- Cancer Lett, 2025 (first author): A multicenter, real-world study analysis: pembrolizumab changes treatment strategy for the patient with recurrent/metastatic head and neck squamous cell carcinoma. PubMed 40846296
- Nucl Med Mol Imaging, 2025 (senior author): (18)F-FAPI-04 PET/CT Imaging of Rare Brain Metastasis from Myxoid Pleomorphic Liposarcoma. PubMed 40686826
- Cancer Biomark, 2025 (senior author): The change of soluble programmed cell death ligand-1 (sPD-L1): A new predictor of prognosis in hypopharyngeal squamous cell carcinoma patients treated with radiotherapy. PubMed 40420575
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion